Matrix metalloproteinase (MMP ) -1 and -3 promoter polymorphisms in Bulgarian patients with COPD Source: Annual Congress 2011 - Genetics of airway diseases and treatment Year: 2011
Discoidin domain receptor 1 regulates bronchial epithelial repair and matrix metalloproteinase production Source: Eur Respir J 2011; 37: 1482-1493 Year: 2011
The genetic polymorphism of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011
Expression of adamalysin proteases (A Disintegrin And Metalloprotease) and their inhibitors in sputum from asthmatics Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006
Biological role of matrix metalloproteinases: a critical balance Source: Eur Respir J 2011; 37: 191-208 Year: 2011
Metalloproteinases (MMPs), tissue inhibitors of metalloproteinases (TIMPs) and transforming growth factor (TGFβ) in pleural tuberculosis Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008
Effects of keratinocyte growth factor (KGF) on matrix metalloproteinases (MMPs) & tissue inhibitors of metalloproteinases (TIMPs) mRNA levels in emphysematous rats lungs Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008
Expression of A D isintegrin a nd M etalloprotease (ADAM) enzymes in human squamous cell lung carcinomas Source: Eur Respir J 2004; 24: Suppl. 48, 704s Year: 2004
Remodelling of extracellular matrix (ECM) differs between pulmonary adenocarcinoma (Ad) and squamous cell carcinoma (Sq): immunohistochemistry and morphometry of matrix proteins (MPs), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (TIMPs Source: Annual Congress 2008 - Novel targets in the molecular pathology of lung cancer and COPD Year: 2008
Fine mapping of matrix metalloproteinase 16 (MMP16) gene: Validation of a significant association with bronchopulmonary dysplasia (BPD) Source: Annual Congress 2010 - Lung cancer, idiopathic pulmonary fibrosis and sarcoidosis: the genetic approach Year: 2010
Metalloproteinase-9 and tissue inhibitor of metalloproteinase in baker‘s asthma Source: Eur Respir J 2005; 26: Suppl. 49, 603s Year: 2005
Blood levels of matrix metalloproteinases (MMPs) and tissue inhibitors of matrix matalloproteinases (TIMPs) as biomarkers of COPD. Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018
The role of matrix metalloproteinase- 9 (MMP-9) and tissue inhibitor of matrix metalloproteinase-1 (TIMMP-1) in sarcoidosis and idiopathic pulmonary fibrosis. Correlation with echocardiography Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006
Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in pleural effusions Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011
Matrix remodeling in IPF: the important role of MMPs-1, -2, -9 and TIMP-1, TIM-2 Source: Eur Respir J 2004; 24: Suppl. 48, 455s Year: 2004
Remodelling of extracellular matrix (ECM) differs between tumor centre and invasion front in human non-small cell lung cancer: immunohistochemistry and morphometry of matrix proteins (MP), matrix metalloproteinases (MMPs), and tissue inhibitors of MMPs (T Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases Year: 2008
Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF Source: Eur Respir J 2002; 20: 1220-1227 Year: 2002
Microarrays reveal coordinated expression of ADAMs family of genes in an in vitro model of pulmonary fibrosis Source: Annual Congress 2005 - Progresses in lung fibrosis Year: 2005
Matrix metalloproteinase (MMP) 9 is associated with clinical parameters of severity in cystic fibrosis (CF) Source: Annual Congress 2010 - Cystic fibrosis: lung disease and much more Year: 2010
Potential role of ADAM (A Disintegrin And Metalloprotease) in malignant pleural mesothelioma resistance to chemotherapy. Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside Year: 2020